Electromyographic evidence of subclinical myopathy in hypertrophic cardiomyopathy

N Karandreas1, P Stathis, A Anastasakis

  • 1EMG Laboratory, Department of Neurology, Aeginition Hospital, University of Athens, Vas. Sofias 72-74, 11528 Athens, Greece. nekaran@hotmail.com

Muscle & Nerve
|December 5, 2000
PubMed

Insights

Electromyography (EMG) can detect skeletal muscle involvement in hypertrophic cardiomyopathy (HCM). Quantitative EMG (QEMG) shows myopathic findings in 15% of HCM patients, suggesting distinct genetic subtypes.

Area of Science:

  • Cardiology
  • Neurology
  • Genetics

Background:

  • Hypertrophic cardiomyopathy (HCM) is a genetic heart condition caused by mutations in contractile protein genes.
  • Some HCM-associated gene mutations, particularly in beta-myosin, involve skeletal muscle and may influence prognosis.
  • The potential for skeletal muscle involvement in HCM necessitates methods for its detection.

Purpose of the Study:

  • To evaluate the utility of electromyography (EMG) and quantitative electromyography (QEMG) in identifying skeletal muscle abnormalities in patients with HCM.
  • To determine the prevalence of myopathic findings in an HCM cohort using EMG techniques.
  • To explore whether EMG findings correlate with different genetic substrates in HCM.

Main Methods:

  • A cohort of 46 patients with HCM underwent conventional EMG and QEMG.
  • QEMG included motor unit potential (MUP) analysis, turns/amplitude (TAA) analysis, and power spectrum analysis.
  • Receiver operating characteristic (ROC) analysis was used to assess the diagnostic accuracy of QEMG parameters.

Main Results:

  • Conventional EMG revealed myopathic findings in 28% (13 out of 46) of HCM patients.
  • QEMG analysis, using a discriminant function, correctly identified normal controls and myopathic controls.
  • QEMG indicated a 15% prevalence of myopathy (7 patients) within the HCM group, with MUP duration being the most sensitive indicator.
  • These findings suggest that skeletal muscle involvement is present in a subset of HCM patients.

Conclusions:

  • Electromyography, particularly QEMG, is a valuable tool for detecting skeletal muscle involvement in hypertrophic cardiomyopathy.
  • The presence of myopathic findings in HCM patients may signify distinct subpopulations with different genetic underpinnings.
  • Further research into the genetic basis of these HCM subpopulations identified by EMG is warranted.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Structure of Cardiac Muscles01:13

Structure of Cardiac Muscles

Cardiac muscle, or myocardium, is a specialized type of muscle found exclusively in the heart. Its unique structural and functional characteristics enable the heart to perform its vital role of pumping blood throughout the body continuously and rhythmically. The cardiac muscle cells, or cardiomyocytes, possess an endomysium and perimysium but do not have an epimysium.
Compared to skeletal muscles, cardiac muscle cells are small and mostly have a single nucleus. Additionally, they are usually...